Peptech name change to Arana Therapeutics
Peptech has announced an official name change to Arana Therapeutics. The company’s ASX code will change to AAH this week and its code on the London Stock Exchange has been changed to AAHx.
Arana Therapeutics, created by the merger of Peptech and EvoGenix in August 2007, is focused on developing antibody/protein-based new generation products and platforms for the treatment of inflammatory diseases and cancer.
“This final step in the merger of Peptech and EvoGenix creates a true global player in the antibody therapeutics sector,” said Robin Beaumont, chairman of Arana Therapeutics.
“As well as critical mass, Arana Therapeutics has the right mix of people, skills, technologies and, most importantly, financial backing to achieve international recognition. Our key focus now is to rapidly develop our exciting product pipeline.”
AI.gov.au launches to help safe and responsible AI use
Providing guidance, tools and resources to help Australian businesses use AI safely, the...
AusBiotech responds to Budget 2026–27
The life sciences industry body has responded to measures set out in the Australian...
$6.2m for nine science projects involving Japan and neighbours
Investments under the Global Science and Technology Diplomacy Fund will support nine...
